| 0.085 Data as of Jun 17 |  -0.005 / -5.56%Today’s Change | 0.06 Today|||52-Week Range 3.02 | -97.00% Year-to-Date |
| Previous close | 0.09 |
| Today’s open | 0.09 |
| Day’s range | 0.09 - 0.09 |
| Volume | 918 |
| Average volume (3 months) | 104,060 |
| Market cap | $3.1M |
| Dividend yield | -- |
| Earnings growth (last year) | +22.37% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.03 |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$31.2M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Jonathan Couchman |
Chief Financial Officer, Secretary & Treasurer Andrea E. Kendell |
Corporate headquarters Salt Lake City, Utah |
.
